Jump Financial LLC Purchases 7,159 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Jump Financial LLC boosted its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 29.2% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 31,666 shares of the company's stock after acquiring an additional 7,159 shares during the period. Jump Financial LLC's holdings in Ryan Specialty were worth $2,032,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in RYAN. XTX Topco Ltd grew its holdings in shares of Ryan Specialty by 312.6% in the fourth quarter. XTX Topco Ltd now owns 19,033 shares of the company's stock valued at $1,221,000 after purchasing an additional 14,420 shares during the period. Mariner LLC raised its position in shares of Ryan Specialty by 3.4% during the 4th quarter. Mariner LLC now owns 5,278 shares of the company's stock worth $339,000 after acquiring an additional 172 shares in the last quarter. Barclays PLC increased its position in shares of Ryan Specialty by 3.0% during the fourth quarter. Barclays PLC now owns 1,690,279 shares of the company's stock worth $108,449,000 after purchasing an additional 48,536 shares in the last quarter. Summit Investment Advisors Inc. boosted its holdings in shares of Ryan Specialty by 1.5% in the fourth quarter. Summit Investment Advisors Inc. now owns 21,311 shares of the company's stock valued at $1,367,000 after acquiring an additional 323 shares during the period. Finally, Synovus Financial Corp boosted its stake in shares of Ryan Specialty by 1.6% during the fourth quarter. Synovus Financial Corp now owns 50,594 shares of the company's stock worth $3,246,000 after buying an additional 804 shares during the period. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Ryan Specialty Stock Performance

Shares of Ryan Specialty stock traded up $0.08 during trading hours on Thursday, reaching $69.50. The company's stock had a trading volume of 170,606 shares, compared to its average volume of 948,986. The stock has a market cap of $18.20 billion, a P/E ratio of 100.71, a price-to-earnings-growth ratio of 1.19 and a beta of 0.66. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. Ryan Specialty Holdings, Inc. has a one year low of $48.48 and a one year high of $77.16. The company's 50 day simple moving average is $70.51 and its 200 day simple moving average is $69.00.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. As a group, analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Tuesday, March 4th were given a $0.12 dividend. The ex-dividend date was Tuesday, March 4th. This is a boost from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a yield of 0.69%. Ryan Specialty's payout ratio is 69.57%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. UBS Group lifted their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Royal Bank of Canada lowered their price objective on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a report on Friday, February 21st. Wells Fargo & Company decreased their price target on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. TD Cowen started coverage on shares of Ryan Specialty in a report on Thursday, April 10th. They issued a "buy" rating and a $89.00 price target for the company. Finally, Barclays cut their price objective on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research report on Friday, April 11th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $75.67.

Insider Activity

In other news, Director Nicholas Dominic Cortezi sold 31,409 shares of the business's stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $65.64, for a total transaction of $2,061,686.76. Following the sale, the director now owns 2,697 shares in the company, valued at $177,031.08. The trade was a 92.09 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 96,409 shares of company stock worth $6,424,437. Corporate insiders own 11.10% of the company's stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.